Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2684 |
|
Actual shortage: | 240 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2435 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
27 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-TEMOZOLOMIDE | 250MG | CAPSULE | Resolved | 2023-01-19 | 2023-04-28 | 181628 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2023-02-02 | 2023-07-05 | 183361 |
ACT TERBINAFINE | 250MG | TABLET | Resolved | 2023-02-09 | 2023-07-05 | 184195 |
TEVA-NAPROXEN EC | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2023-04-27 | 2023-06-09 | 190740 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2023-06-16 | 2023-11-03 | 195109 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2023-06-16 | 2023-10-11 | 195112 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2023-06-16 | 2023-10-11 | 195207 |
NOVAMOXIN | 250MG | TABLET (CHEWABLE) | Resolved | 2023-06-19 | 2023-08-18 | 195545 |
TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Resolved | 2023-06-19 | 2023-06-27 | 195554 |
ACT CIPROFLOXACIN | 250MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195585 |
ACT TERBINAFINE | 250MG | TABLET | Resolved | 2023-06-19 | 2023-08-17 | 195629 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2023-06-20 | 2023-11-03 | 195754 |
TEVA-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2023-06-20 | 2023-07-05 | 195870 |
TEVA-CEPHALEXIN | 250MG | CAPSULE | Resolved | 2023-06-20 | 2023-07-06 | 195894 |
TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Resolved | 2023-07-06 | 2023-07-28 | 197743 |
TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Resolved | 2023-08-03 | 2024-04-25 | 200864 |
TEVA-TEMOZOLOMIDE | 250MG | CAPSULE | Actual shortage | 2023-10-12 | 2024-02-07 | 206901 |
TEVA-CEPHALEXIN 250 | 250MG | POWDER FOR SUSPENSION | Resolved | 2023-10-19 | 2024-02-15 | 207500 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Actual shortage | 2023-10-19 | 2024-03-18 | 207503 |
TEVA-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2023-10-19 | 2023-12-07 | 207539 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
RATIO-METFORMIN | 850MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 120012 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64855 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64858 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64861 |
TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |